181 related articles for article (PubMed ID: 1376066)
1. Association of bone marrow growth pattern, coexpression of CD14, and B-cell CD5 antigen density in 45 B-chronic lymphocytic leukemia (B-CLL) patients.
Paglieroni T; Caggiano V; MacKenzie MR
Ann N Y Acad Sci; 1992 May; 651():484-5. PubMed ID: 1376066
[No Abstract] [Full Text] [Related]
2. Immunocytochemical investigation of normal and chronic lymphocytic leukaemia lymphocytes reveals unexpectedly frequent reactivity with some myelomonocytic associated antibodies.
Woessner S; Florensa L; Besses C; Vilà RM; Gallés C; Palou L; Sabrafen JS
Leuk Res; 1992; 16(5):505-10. PubMed ID: 1378160
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
4. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
[TBL] [Abstract][Full Text] [Related]
5. Normal B cell compartment in chronic lymphatic leukemia.
Pluta A; Górski A; Nowaczyk M; Modlińska M
Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
[TBL] [Abstract][Full Text] [Related]
6. Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia.
Pinto A; Del Vecchio L; Carbone A; Roncadin M; Volpe R; Serraino D; Monfardini S; Colombatti A; Zagonel V
Ann Oncol; 1991 Feb; 2 Suppl 2():107-13. PubMed ID: 2049307
[TBL] [Abstract][Full Text] [Related]
7. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
8. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kampalath B; Barcos MP; Stewart C
Am J Clin Pathol; 2003 Jun; 119(6):824-32. PubMed ID: 12817430
[TBL] [Abstract][Full Text] [Related]
11. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia.
Gale RP; Caligaris-Cappio F; Dighiero G; Keating M; Montserrat E; Rai K
Leukemia; 1994 Sep; 8(9):1610-4. PubMed ID: 7522296
[TBL] [Abstract][Full Text] [Related]
14. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
15. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression.
Prieto D; Oppezzo P
Molecules; 2017 Dec; 22(12):. PubMed ID: 29206143
[TBL] [Abstract][Full Text] [Related]
17. [Cell membrane characteristics of B-lymphocytes in chronic lymphocytic leukemia. II. Expression of B-cell markers].
Pluta A; Górski A; Nowaczyk M
Pol Arch Med Wewn; 1991 Sep; 86(3):154-8. PubMed ID: 1725559
[TBL] [Abstract][Full Text] [Related]
18. MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis.
Warzynski MJ; Otto RN; Steingart RH; White CF; Rosen MH; Hetzel PC; Flatow FA; Podgurski AE; Johnson ML
Leuk Res; 1991; 15(5):357-65. PubMed ID: 2046387
[TBL] [Abstract][Full Text] [Related]
19. [Membrane characteristics of pathological clones of B-lymphocytes in patients with chronic lymphocytes leukemia (CLL)].
Pluta A
Pol Arch Med Wewn; 1989; 82(4-6):195-201. PubMed ID: 2642224
[No Abstract] [Full Text] [Related]
20. Myelo-monocytoid immunophenotypes of B-cell chronic lymphocytic leukemia cells.
Tsuda H; Matsumi S; Nishimura H; Kawano F; Shido T; Takatsuki K
Intern Med; 1993 Jul; 32(7):533-9. PubMed ID: 8286829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
